Opioids—a class of medicines commonly given for pain—were associated with a higher risk of pneumonia in a study of 3,061 adults, aged 65 to 94, e-published in advance of publication in the Journal of the American Geriatrics Society. The study from researchers at Group Health Research Institute and the University of Washington (UW) also found that benzodiazepines, which are drugs generally given for insomnia and anxiety, did not affect pneumonia risk.
Washington’s highest-in-the-nation immunization exemption rate may be inviting a full-blown outbreak of vaccine-preventable disease.
A report in the August 2011 issue of Health Affairs describes a major initiative at Group Health to make opioid prescribing safer while improving care for patients with chronic pain. Health Affairs is the nation’s premier health policy journal, and its August issue focuses on substance abuse.
First randomized trial of shared decision making for weight-loss surgery.
Guided by research and monitoring patients, Group Health’s new initiative for safer opioid prescribing has produced stunning results in just nine months. Claire Trescott, MD, medical director of primary care, leads this innovative effort to protect patient safety at Group Health—and nationwide.
Last month, the federal government disclosed—then quickly abandoned—a plan to unleash “mystery shoppers” on 4,000 primary care practices across the United States. The goal? To see just how many providers refuse to take new Medicare and Medicaid patients.
Daniel C. Cherkin, PhD, and Karen J. Sherman, PhD, MPH, made headlines this week with their latest research on massage for back pain. Here, they reflect on their decade of investigating complementary and alternative medicine therapies
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.